ARCHIVES

Senate Investigates Opioid Manufacturers, Requests Study of Impact of DEA Policies

This article is from The Cancer Letter archive.

Vol. 38 No. 19 | May 11, 2012

Download PDF Visit The Full Archive

Related Articles

AACR Polls Members On Tentative Date for Annual Meeting

April 11, 2003

Cancer Prevention: HHS Calls for Warning Labels on Cigars, Says Teen Use High

March 5, 1999

NSABP Accrual Slow, But Auditing Called “Impressive”

January 20, 1995

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

NCI-Approved Clinical Trials Listed For Month Of March

April 27, 2001

Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS

September 27, 1991